Abstracts Listed by Title and Author

Session One

Keynote Speaker
CLA in Human and Animal Health: Mechanisms and Prospects
Pariza, Michael W.

Session Two

The Chemistry and Prevalence of CA Isomers in Animal Systems
Kramer, John K.G. Zhou, J., Cruz-Hernandez,C. and Dugan, M.

Keynote Speaker
Cellular and Molecular Mechanisms of CLA Action
Belury, Martha A.

Session Three

The Metabolic Syndrome and the Effects of CLA in Obesity, Diabetes and Lipoprotein Disorders: The Quebec Experience
Lamarche, Benoît

CLA Effects In Obese Hyperinsulinemic FA/FA Zucker Rats
Taylor, Carla G., Yurkova,N., Noto, A., T. Ryz, T., Truong, H., Zahradka, J., Zirk, M. &
Zahradka, P.

Body Composition/Adipose Mass and Conjugated Linoleic Acid Effects
Jones, Peter J.

Keynote Speaker
The Metabolic Effects of CLA in Humans: The Swedish Experience.
Vessby, Bengt, Risèrus, U., Smedman, A., Basu, S.

Session Four

Insulin Resistance-Associated Cardiovascular Disease: Potential Benefits of CLA.
Anderson, Hope D.

Effects of CLA on Hepatic Very Low Density Lipoprotein Metabolism
McLeod, R. S., LeBlanc, A., Langille, M. & Currie, D.

Actions of Conjugated Linoleic Acid on Bone Metabolism
Watkins, Bruce, Li,Y., Lippman, H., Feng, S., Seifert, M.

Dietary Conjugated Linoleic Acid (CLA) as a potential treatment for metabolic bone disease
Weiler, Hope, Austin,S., Fitzpatrick-Wong, S., Nitschmann, E., Bankovic-Calic, N., Mollard,R.,
Aukema, H., Ogborn, M.

Session Five

Evidence for Potential Mechanisms for the Effect of CLA on Tumor Metabolism and Immune Function: Lessons From N-3 Fatty Acids.
Field, C.

Session Six

Keynote Speaker
Linking Human Health Research to Product Development and Marketing
Thorvaldson, C.L.

CLA-Enriched Dairy Production
Chouinard, P.Y.

Conjugated Linoleic Acid (CLA) Enriched Beef Production
Mir, Priya S., McAllister, T. A., Mir, Z., Scott, S., Aalhus, J., Baron, V., McCartney, D.,
Charmley, E., Goonewardene, L., Basarab, J., Okine, E., Weselake, R.J.

CLA Pork Research
Dugan, Michael E.R., Aalhus, J. L., and Kramer, J.K.G.

Session Seven

Developing CLA-Enriched Dairy Products
McNish, Brad

Regulatory Issues in the Use of CLA in Functional Foods & Natural Health Products in Canada
Fitzpatrick, Kelley C.

Modulation of the Immune Response by Conjugated Linoleic Acid: Clinical Development from an Industry Perspective
O'Shea, Marianne, Bassaganya-Riera, J., Hontecillas, R., and Mohede, I.

Poster Abstracts listed by Title and Author

Dietary Conjugated Linoleic Acid (CLA) Effects on the Kidney
Aukema, Harold, Ogborn, M.R., Evans, L.I, Weiler,H.A., Nitschmann, E.& Bankovic-Calic, N.

Trans-9,Trans-11 Conjugated Linoleic Acid Decreases Triglyceride Accumulation in Primary Cultures of Pre-Adipocytes from Human and Hamster Adipose Tissues
Gavino, V.C., Gavino, G.G.and Pelletier, R.M.

Effects of Linoleic Acid (LA) and Conjugated Linoleic Acid (CLA) on Leptin
Plett, Patti, Weiler, H., Angel, A.

Dietary Conjugated Linoleic Acid (CLA) Regulates PPAR-Responsive Genes and Improves Characteristics of the Metabolic Syndrome in Insulin-Resistant Obese Rats
Natalia Yukova, Noto, A., Ryz, T., Zahradka, J., Zirk, M., Zahradka, P. and Taylor, C.